FEDIFAR considered exhausted the route of pharmacy pharmaceutical spending cuts to sustain the SNS.
down the invoice in drugs in 2011 a 8.78%. Joins the 2010 fall
from 2.36%
-the patron saint of pharmaceutical distribution (FEDIFAR) considers that the contribution of the pharmaceutical sector to the sustainability of the national health system is unquestionable and clearly enough
-sector has undergone in 2010 and 2011, at the State level, of very harsh measures which have placed the companies on the verge of its viability. For pharmaceutical distribution, these cuts have resulted in a minimum of approximately 1.8 billion euros less than billing
-FEDIFAR requests and health authorities to consider other avenues of health care cost containment alternatives to cut the public Bill in medicines based on structural measures to improve the efficiency of the SNS in the medium and long term to ensure the survival of the health care model Spanish and the related companies
Spain, January 2012- the Spanish pharmaceutical distribution Federation (FEDIFAR) through cuts in spending on Drugs considered exhausted to sustain the national system of health (SNS). The central and regional Governments have reduced the public Bill in medicines by 2.36% in 2010 and 8.78% in 2011, according to figures announced last Friday by the Ministry of health, social services and equality.
For FEDIFAR pharmaceutical sector to the sustainability of the SNS’s contribution is more than enough and it has already been more than demonstrated the commitment of the sector with the difficult economic situation affecting the country.
Continue elaborating on cuts in the Bill on drugs would be the final blow to businesses with its viability already compromised, with the consequent loss of employment and investment, which is the last thing that needs Spain.
Pharmaceutical distribution companies already took a hit which has meant less income € 1,190 million in 2010. And new measures by the Government in 2011 will be minimal impact of approximately EUR 360 million for distribution, and a planned overall saving of 2.4 billion, which will be subtracted from the income of the sector. This adds up to the constant cuts prices and margins (set by law) in recent years.
If to this we add delays and defaults of the public Bill for medicines that pharmacy (and, consequently, the distribution companies) are experiencing in some autonomous communities, the scenario is complicated.
less accessibility to the drug
and in the health sector, the closure of distribution companies would lead to that citizens be diminished its accessibility to treatment, is the pharmaceutical distribution of full range the responsible for taking all medications at all times and to all corners of the country by remote than are
Thus, FEDIFAR requests the Ministry of health and the ministries of industry that not abundant in cuts in the public Bill on drugs to be sold in pharmacies (is the heading to which they refer official data and the more controlled).
Likewise, the Federation requested that alternative ways of improving efficiency in the NHS explore. The sample that there are way to go in the rational use of medicines is that, despite lower bills a 8.78%, the number of prescriptions has continued to rise (1.62% in 2011), so there is room for progress in demand and fail to act on the offer (agents of the sector).
For FEDIFAR, the sustainability of the passes SNS for efficiency, but also to devote adequate resources for the financing of health care, and notes with concern that the majority of CCAA have budgeted for 2012 below the cost of 2011 health in general and pharmaceutical in particular. The concern is greater if one takes into account that the CCAA does not steps are being taken of draught in the improvement of efficiency alternatives to actions in the field of medicine.
The Federation has proposed to the Ministry and the autonomous communities the joint search for solutions that do not harm the economy of the companies in the sector. more
who we are
the Federation of pharmaceutical distributors (FEDIFAR) is composed of 52 wide range distribution companies, with a combined market share above 97%.
High-end pharmaceutical distribution makes it possible that the entire Spanish population has equal access to medicines irrespective of the place where they reside. His activity means that all pharmacies of the territory receive equal all drugs marketed in Spain.
To achieve this, the distribution of wide range is based on the solidarity model of distribution: detract benefits of expensive products and high rotation to subsidize the service of cheap products and low rotation.
